Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

@article{Veselka2016LongtermCO,
  title={Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.},
  author={Josef Veselka and Morten Kvistholm Jensen and Max Liebregts and Jaroslav Janu{\vs}ka and Jan Krejci and Thomas W. Bartel and Maciej Dąbrowski and Peter Riis Hansen and Vibeke Marie Almaas and Hubert Seggewiss and Dieter Horstkotte and Pavol Toma{\vs}ov and Radka Adlov{\'a} and Henning Bundgaard and Robbert C. Steggerda and Jurri{\"e}n Maria ten Berg and Lothar Faber},
  journal={European heart journal},
  year={2016},
  volume={37 19},
  pages={
          1517-23
        }
}
AIMS The first cases of alcohol septal ablation (ASA) for obstructive hypertrophic cardiomyopathy (HCM) were published two decades ago. Although the outcomes of single-centre and national ASA registries have been published, the long-term survival and clinical outcome of the procedure are still debated. METHODS AND RESULTS We report long-term outcomes from the as yet largest multinational ASA registry (the Euro-ASA registry). A total of 1275 (58 ± 14 years, median follow-up 5.7 years) highly… CONTINUE READING

Similar Papers

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Hypertrophic obstructive cardiomyopathy: what, when, why, for whom?

  • European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • 2018
VIEW 9 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Septal reduction therapy using nonalcohol agent in hypertrophic obstructive cardiomyopathy: Single center experience.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2018

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES